Viatris initiated at Outperform, $20 price target by Leerink
Leerink Partners initiated coverage on Viatris with an Outperform rating and a $20.00/share price target.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.